资讯

2 Beaten-Down Stocks With Incredible Upside Potential
Iovance Biotherapeutics (NASDAQ: IOVA) and CRISPR Therapeutics (NASDAQ: CRSP) are two incredibly innovative biotechs, but ...
The Lancet1 天
Unlocking tumor-infiltrating lymphocyte potential with CRISPR-Cas9
Adoptive cell therapy based on ex-vivo expanded tumor-infiltrating lymphocytes (TILs) has historically been most effective in the treatment of metastatic melanoma,1 with objective response rates of up ...
Kytopen and Aldevron Expedite Cell Therapy Manufacturing Through Their Collaborative CRISPR ...
Kytopen Corp., a leader in providing non-viral, continuous flow cellular engineering technologies and Aldevron, a leading global manufacturer serving organizations in the gene editing, mRNA vaccine ...
EMBO Press1 天
Time-resolved mitochondrial screen identifies regulatory components of oxidative metabolism
A CRISPR/Cas9-based galactose screening identifies key mitochondrial genes involved in OXPHOS and oxidative metabolism, ...
Crispr Therapeutics Benefits From Diverse Gene Editing Portfolio; Positive Long-Term Outlook
Crispr Therapeutics is an emerging gene editing company focused on the development of Crispr/Cas9-based therapeutics. The company's proprietary platform specializes in clustered regularly interspaced ...
Tiny CRISPR tool opens door to faster, simpler plant genome editing
Plant breeding plays a vital role in ensuring global food security by increasing crop yields, improving nutritional quality ...
Newseria BIZNES6 天
Exploring the Genome: How Creative Biolabs Leads the Way in the Future of CRISPR Gene Editing
In the vast territories of the genome, Creative Biolabs uses CRISPR gene-editing technologies to rewrite the rules of genetic research and therapy development. SHIRLEY, NY, UNITED STATES, April 24, ...